Related references
Note: Only part of the references are listed.A Pragmatic Cluster-Randomized Trial of Provider Education and Community Health Worker Support for Tobacco Cessation
A. Eden Evins et al.
PSYCHIATRIC SERVICES (2023)
Smoking Cessation Medication Prescribing for Smokers With and Without Mental Illness
Sarah A. White et al.
PSYCHIATRIC SERVICES (2023)
Addressing Barriers to Provision of First-Line Pharmacotherapy for Tobacco Use Disorder
Eden Evins et al.
PSYCHIATRIC SERVICES (2023)
Efficacy and Safety of Pharmacotherapeutic Smoking Cessation Aids in Schizophrenia Spectrum Disorders: Subgroup Analysis of EAGLES
A. Eden Evins et al.
PSYCHIATRIC SERVICES (2021)
Risk factors for natural cause mortality in a cohort of 1494 persons with serious mental illness
Faith Dickerson et al.
PSYCHIATRY RESEARCH (2021)
Assessing barriers to providing tobacco use disorder treatment in community mental health settings with a revised version of the Smoking Knowledge, Attitudes, and Practices (S-KAP) instrument
Scott D. Siegel et al.
ADDICTIVE BEHAVIORS (2021)
Initiating Pharmacologic Treatment in Tobacco-Dependent Adults An Official American Thoracic Society Clinical Practice Guideline
Frank T. Leone et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Effect of a Comprehensive Cardiovascular Risk Reduction Intervention in Persons With Serious Mental Illness A Randomized Clinical Trial
Gail L. Daumit et al.
JAMA NETWORK OPEN (2020)
Effectiveness of Proactive Tobacco Cessation Treatment Outreach Among Smokers With Serious Mental Illness
Sandra J. Japuntich et al.
NICOTINE & TOBACCO RESEARCH (2020)
Biochemical Verification of Tobacco Use and Abstinence: 2019 Update
Neal L. Benowitz et al.
NICOTINE & TOBACCO RESEARCH (2020)
Prescribing Prevalence, Effectiveness, and Mental Health Safety of Smoking Cessation Medicines in Patients With Mental Disorders
Gemma M. J. Taylor et al.
NICOTINE & TOBACCO RESEARCH (2020)
Safety and efficacy of first-line smoking cessation pharmacotherapies in bipolar disorders: Subgroup analysis of a randomized clinical trial
Jaimee L. Heffner et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
A Cluster-Randomized Clinical Trial Testing the Effectiveness of the Addressing Tobacco Through Organizational Change Model for Improving the Treatment of Tobacco Use in Community Mental Health Care: Preliminary Study Feasibility and Baseline Findings
Alex S. Flitter et al.
NICOTINE & TOBACCO RESEARCH (2019)
Smoking cessation for people with severe mental illness (SCIMITAR plus ): a pragmatic randomised controlled trial
Simon Gilbody et al.
LANCET PSYCHIATRY (2019)
Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial
A. Eden Evins et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2019)
A Qualitative Evaluation of Mental Health Clinic Staff Perceptions of Barriers and Facilitators to Treating Tobacco Use
Erin S. Rogers et al.
NICOTINE & TOBACCO RESEARCH (2018)
Cigarette Smoking by Patients With Serious Mental Illness, 1999-2016: An Increasing Disparity
Faith Dickerson et al.
PSYCHIATRIC SERVICES (2018)
Randomized Trial of Interventions for Smoking Cessation Among Medicaid Beneficiaries With Mental Illness
Mary F. Brunette et al.
PSYCHIATRIC SERVICES (2018)
2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents
Rajat S. Barua et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Combination Extended Smoking Cessation Treatment Plus Home Visits for Smokers With Schizophrenia: A Randomized Controlled Trial
Arthur L. Brody et al.
NICOTINE & TOBACCO RESEARCH (2017)
Maintenance pharmacotherapy normalizes the relapse curve in recently abstinent tobacco smokers with schizophrenia and bipolar disorder
A. Eden Evins et al.
SCHIZOPHRENIA RESEARCH (2017)
Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas
Nancy H. Liu et al.
WORLD PSYCHIATRY (2017)
Smoking Cessation and Electronic Cigarettes in Community Mental Health Centers: Patient and Provider Perspectives
Li-Shiun Chen et al.
COMMUNITY MENTAL HEALTH JOURNAL (2017)
Interventions to Address Medical Conditions and Health-Risk Behaviors Among Persons With Serious Mental Illness: A Comprehensive Review
Emma E. McGinty et al.
SCHIZOPHRENIA BULLETIN (2016)
Weight Gain and 10-Year Cardiovascular Risk With Sustained Tobacco Abstinence in Smokers With Serious Mental Illness: A Subgroup Analysis of a Randomized Trial
Anne N. Thorndike et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial
Robert M. Anthenelli et al.
LANCET (2016)
Premature Mortality Among Adults With Schizophrenia in the United States
Mark Olfson et al.
JAMA PSYCHIATRY (2015)
Mortality in Mental Disorders and Global Disease Burden Implications A Systematic Review and Meta-analysis
Elizabeth Reisinger Walker et al.
JAMA PSYCHIATRY (2015)
Smoking Cessation in Individuals With Serious Mental Illness: A Randomized Controlled Trial of Two Psychosocial Interventions
Melanie E. Bennett et al.
JOURNAL OF DUAL DIAGNOSIS (2015)
Bespoke smoking cessation for people with severe mental ill health (SCIMITAR): a pilot randomised controlled trial
Simon Gilbody et al.
LANCET PSYCHIATRY (2015)
Factors Influencing Implementation of Smoking Cessation Treatment Within Community Mental Health Centers
Clayton H. Brown et al.
JOURNAL OF DUAL DIAGNOSIS (2015)
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
David C. Goff et al.
CIRCULATION (2014)
Trends in Smoking Among Adults With Mental Illness and Association Between Mental Health Treatment and Smoking Cessation
Benjamin Le Cook et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Maintenance Treatment With Varenicline for Smoking Cessation in Patients With Schizophrenia and Bipolar Disorder A Randomized Clinical Trial
A. Eden Evins et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Varenicline for Smoking Cessation in Bipolar Disorder: A Randomized, Double-Blind, Placebo-Controlled Study
K. N. Roy Chengappa et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Barriers to Implementing Evidence-Based Smoking Cessation Practices in Nine Community Mental Health Sites
Seth Himelhoch et al.
PSYCHIATRIC SERVICES (2014)
Interventions for smoking cessation and reduction in individuals with schizophrenia
Daniel T. Tsoi et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Varenicline for Smoking Cessation in Patients With Schizophrenia or Schizoaffective Disorder
Jill M. Williams et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Smoking and Mental Illness - Breaking the Link
Judith J. Prochaska
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Smoking Characteristics of Adults With Selected Lifetime Mental Illnesses: Results From the 2007 National Health Interview Survey
Annette K. McClave et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2010)
Obesity Among Those with Mental Disorders A National Institute of Mental Health Meeting Report
David B. Allison et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2009)
General cardiovascular risk profile for use in primary care - The Framingham Heart Study
Ralph B. D'Agostino et al.
CIRCULATION (2008)
Cognitive behavioural therapy for weight gain associated with antipsychotic drugs
Yasser Khazaal et al.
SCHIZOPHRENIA RESEARCH (2007)
Treatment for cigarette smoking among depressed mental health outpatients: A randomized clinical trial
Sharon M. Hall et al.
AMERICAN JOURNAL OF PUBLIC HEALTH (2006)
Effect of cognitive behavior therapy on smokers' compensatory coping skills
Frances P. Thorndike et al.
ADDICTIVE BEHAVIORS (2006)
Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation -: A randomized controlled trial
David Gonzales et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Effect of maintenance therapy with varenicline on smoking cessation - A randomized controlled trial
Serena Tonstad et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial and comparison with national estimates from NHANES III
JP McEvoy et al.
SCHIZOPHRENIA RESEARCH (2005)
Urine cotinine as an index of smoking status in smokers during 96-hr abstinence: Comparison between gas chromatography/mass spectrometry and immunoassay test strips
MC Acosta et al.
NICOTINE & TOBACCO RESEARCH (2004)
Prevalence and correlates of obesity in a community sample of individuals with severe and persistent mental illness
GL Daumit et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2003)
Illness management and recovery: A review of the research
KT Mueser et al.
PSYCHIATRIC SERVICES (2002)
Share Paper
